Yi I. Cai

No.87 Xiangya Road
Changsha, 410008, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 105 publications

Non-invasive evaluation of muscle invasion and survival prognosis in bladder cancer using enhanced CT-based deep learning radiomics: a multi-center real-world cohort study.

Non-invasive evaluation of muscle invasion and survival prognosis in bladder cancer using enhanced CT-based deep learning radiomics: a multi-center real-world cohort study.

Journal: Military Medical Research

Published: June 19, 2026

First-in-human evaluation of [18F]-AlF-NOTA-neurotensin for NTSR1-targeted imaging of prostate cancer: a head-to-head comparison with [68Ga]Ga-PSMA-617.

First-in-human evaluation of [18F]-AlF-NOTA-neurotensin for NTSR1-targeted imaging of prostate cancer: a head-to-head comparison with [68Ga]Ga-PSMA-617.

Journal: Annals of medicine

Published: June 17, 2026

Integrating PET and Fluorescence Imaging with a Novel PSMA-ICG Conjugate for Prostate Cancer Management.

Integrating PET and Fluorescence Imaging with a Novel PSMA-ICG Conjugate for Prostate Cancer Management.

Journal: Molecular pharmaceutics

Published: May 08, 2026

Pelvic lymph node dissection in prostate cancer: current evidence, controversies, and future directions.

Pelvic lymph node dissection in prostate cancer: current evidence, controversies, and future directions.

Journal: Annals of medicine

Published: April 18, 2026

Cross-cohort projection of clinically anchored latent risk enables multi-omics interpretation without refitting.

Cross-cohort projection of clinically anchored latent risk enables multi-omics interpretation without refitting.

Journal: Briefings in bioinformatics

Published: April 07, 2026

PCO26-276: RET-Targeted Theranostics in Neuroendocrine Prostate Cancer: A Novel Molecular Target for Precision Imaging and Therapy.

PCO26-276: RET-Targeted Theranostics in Neuroendocrine Prostate Cancer: A Novel Molecular Target for Precision Imaging and Therapy.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: April 01, 2026

BPI26-007: Avoiding Unnecessary Biopsies for Non-Clinically Significant Prostate Cancer in Patients With PSA 4-20 ng/mL Using PRIMARY Score ≤3 and PSAD ≤0.2 ng/mL/cm³: A Real-World, Dual-Centre Study From China.

BPI26-007: Avoiding Unnecessary Biopsies for Non-Clinically Significant Prostate Cancer in Patients With PSA 4-20 ng/mL Using PRIMARY Score ≤3 and PSAD ≤0.2 ng/mL/cm³: A Real-World, Dual-Centre Study From China.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: March 31, 2026

Integrating large language models into prostate cancer training: evidence from comparative benchmarking and a pilot randomized trial.

Integrating large language models into prostate cancer training: evidence from comparative benchmarking and a pilot randomized trial.

Journal: BMC medical education

Published: January 12, 2026

Non-invasive diagnosis strategy integrating PSMA PET/CT and mpMRI for patients with suspected prostate cancer: a multi-center study.

Non-invasive diagnosis strategy integrating PSMA PET/CT and mpMRI for patients with suspected prostate cancer: a multi-center study.

Journal: BMC medicine

Published: November 26, 2025

Analysis of distant metastasis characteristics in hormone-sensitive and castration-resistant prostate cancer based on prostate-specific membrane antigen PET-CT

Analysis of distant metastasis characteristics in hormone-sensitive and castration-resistant prostate cancer based on prostate-specific membrane antigen PET-CT

Journal: Zhonghua wai ke za zhi [Chinese journal of surgery]

Published: November 11, 2025

Trace-level halogen blocks CO2 emission in Fischer-Tropsch synthesis for olefins production.

Trace-level halogen blocks CO2 emission in Fischer-Tropsch synthesis for olefins production.

Journal: Science (New York, N.Y.)

Published: October 30, 2025

Head-to-Head Comparison of mpMRI, PSMA, GRPR PET/CT, and PET/CT Plus MRI for Local Staging of Primary Prostate Cancer and Their Prognostic Value.

Head-to-Head Comparison of mpMRI, PSMA, GRPR PET/CT, and PET/CT Plus MRI for Local Staging of Primary Prostate Cancer and Their Prognostic Value.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: October 03, 2025

Showing 1-12 of 105

Last Updated: 09/26/2026